Anika Therapeutics, Inc. (ANIK) Operating cash flow 2016–2025
Anika Therapeutics, Inc. (ANIK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$11.2MFY2025 · since FY2016: $24.4M → $11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.2M | +107.1% |
| FY2024 | $5.4M | +402.2% |
| FY2023 | -$1.8M | -140.6% |
| FY2022 | $4.4M | -47.5% |
| FY2021 | $8.4M | -35.7% |
| FY2020 | $13.1M | -64.7% |
| FY2019 | $37.0M | +6.0% |
| FY2018 | $34.9M | -14.4% |
| FY2017 | $40.8M | +66.9% |
| FY2016 | $24.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIK financial trends
ANIK RevenueANIK Net incomeANIK Net marginANIK Gross profitANIK Gross marginANIK Operating incomeANIK Operating marginANIK Free cash flowANIK Capital expendituresANIK Return on equityANIK Stock buybacksANIK Dividends paidANIK Total assetsANIK Total liabilitiesANIK Shareholders’ equityANIK overview →